Patents by Inventor Donato Barbato

Donato Barbato has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240075171
    Abstract: The present invention relates to radionuclide complex solutions of high concentration and of high chemical stability, that allows their use as drug product for diagnostic and/or therapeutic purposes. The stability of the drug product is achieved by at least one stabilizer against radiolytic degradation. The use of two stabilizers introduced during the manufacturing process at different stages was found to be of particular advantage.
    Type: Application
    Filed: October 25, 2023
    Publication date: March 7, 2024
    Inventors: Donato Barbato, Clementina Brambati, Daniela Chicco, Francesco de Palo, Lorenza Fugazza, Maurizio Mariani, Giovanni Tesoriere
  • Patent number: 11904027
    Abstract: The present invention relates to radionuclide complex solutions of high concentration and of high chemical stability, that allows their use as drug product for diagnostic and/or therapeutic purposes. The stability of the drug product is achieved by at least one stabilizer against radiolytic degradation. The use of two stabilizers introduced during the manufacturing process at different stages was found to be of particular advantage.
    Type: Grant
    Filed: March 23, 2020
    Date of Patent: February 20, 2024
    Assignee: Advanced Accelerator Applications
    Inventors: Francesco de Palo, Lorenza Fugazza, Donato Barbato, Maurizio Mariani, Daniela Chicco, Giovanni Tesoriere, Clementina Brambati
  • Publication number: 20230330278
    Abstract: The present disclosure relates to methods for radiolabelling PSMA binding ligands with a radioactive isotope, preferably 68Ga, 67Ga or 64Cu, and their kits.
    Type: Application
    Filed: April 28, 2021
    Publication date: October 19, 2023
    Inventors: Donato BARBATO, Elena CASTALDI, Lorenza FUGAZZA, Mattia TEDESCO
  • Publication number: 20230165980
    Abstract: The present invention relates to methods for labeling a PSMA binding ligand with a radioactive isotope, preferably 68Ga, 67Ga or 64Cu, said method comprising the steps of: i. providing a single vial comprising, in dried form, said PSMA binding ligand f the following formula (I): (I) at least one buffering agent, sodium chloride and a stabilizer against radiolytic degradation, ii. adding a solution of said radioactive isotope into said single vial, thereby obtaining a solution of said PSMA binding ligand of formula (I) with said radioactive isotope, iii. mixing the solution obtained in ii., and incubating it for a sufficient period of time for obtaining said PSMA binding ligand labelled with said radioactive isotope, and, iv. optionally, adjusting the pH of the solution.
    Type: Application
    Filed: April 28, 2021
    Publication date: June 1, 2023
    Inventors: Donato BARBATO, Erica MARTINENGO, Lorenzo SACCHETTI, Mattia TEDESCO
  • Publication number: 20220401593
    Abstract: The present disclosure relates to radionuclide complex solutions of high concentration and of high chemical stability, that allows their use as drug product for diagnostic and/or therapeutic purposes. The stability of the drug product is achieved by at least one stabilizer against radiolytic degradation. The use of two stabilizers introduced during the manufacturing process at different stages was found to be of particular advantage.
    Type: Application
    Filed: September 15, 2020
    Publication date: December 22, 2022
    Inventors: Donato BARBATO, Lorenza FUGAZZA, Maurizio F. MARIANI, Francesca ORLANDI, Lorenzo SACCHETTI, Mattia TEDESCO
  • Publication number: 20220273826
    Abstract: The present disclosure relates to prostate specific membrane antigen (PSMA) ligands In particular, the disclosure relates to PSMA ligands having a glutamate-urea-lysine (GUL) moiety, a radioisotope and a chelating agent that can comprise a radiometal.
    Type: Application
    Filed: June 30, 2020
    Publication date: September 1, 2022
    Inventors: Maurizio F. MARIANI, Donato BARBATO, Francesca ORLANDI
  • Publication number: 20220072166
    Abstract: The present invention relates to methods of treating cancers that overexpress somatostatin receptors, e.g. neuroendocrine tumors (NET). In particular, the invention provides novel therapies based on the combination of a peptide receptor radionuclide therapeutic (PRRT) agent and immuno-oncology (I-O) therapeutic agents, wherein said I-O therapeutic agents are selected from the group consisting of LAG-3 inhibitors, TIM-3 inhibitors, GITR angonists, TGF-? inhibitors, IL15/IL-15RA complex, and selected PD-1 inhibitors.
    Type: Application
    Filed: July 24, 2019
    Publication date: March 10, 2022
    Inventors: Stefano BUONO, Clementina BRAMBATI, Donato BARBATO, Daniela CHICCO, Francesco DE PALO, Lorenza FUGAZZA, Maribel LOPERA-SIERRA, Maurizio MARIANI, Giovanni TESORIERE
  • Publication number: 20220041649
    Abstract: The present disclosure relates to the synthesis of radionuclide complex solutions, in particular for their use in the commercial production of radioactive drug substances, for diagnostic and/or therapeutic purposes. In particular, the synthesis method comprises the following steps in the following order: a. providing a radionuclide precursor solution into a first vial, b. transferring the radionuclide precursor solution into a reactor, c. providing a reaction buffer solution into said first vial containing residual radionuclide precursor solution, d. transferring the buffer reaction solution and residual radionuclide precursor solution from said first vial into the reactor, e. transferring a peptide solution comprising the somatostatin receptor binding peptide linked to a chelating agent, into the reactor, f. reacting the somatostatin receptor binding peptide linked to a chelating agent with said radionuclide in the reactor to obtain the radionuclide complex, g. recovering said radionuclide complex.
    Type: Application
    Filed: May 27, 2021
    Publication date: February 10, 2022
    Applicant: Advanced Accelerator Applications (Italy) S.R.L.
    Inventors: Lorenza Fugazza, Francesco De Palo, Donato Barbato, Maurizio F. Mariani, Giovanni Tesoriere, Clementina Brambati
  • Publication number: 20220031872
    Abstract: It is described a composition comprising lyophilized rhAnnexin V-128 suitable for the preparation of 99mTc-rhAnnexin V-128 formulations suitable for intravenous administration.
    Type: Application
    Filed: August 10, 2021
    Publication date: February 3, 2022
    Applicant: Advanced Accelerator Applications International S.A.
    Inventors: Lorenza Fugazza, Maurizio Franco Mariani, Francesca Orlandi, Daniela Chicco, Donato Barbato
  • Publication number: 20220008566
    Abstract: The present disclosure relates to gastrin-releasing peptide receptor (GRPR) targeting radiopharmaceuticals and uses thereof. In particular, the present disclosure relates to a pharmaceutical composition comprising radiolabeled GRPR-antagonist and a surfactant. The present disclosure also relates to radiolabeled GRPR-antagonist for use in treating or preventing a cancer.
    Type: Application
    Filed: October 11, 2019
    Publication date: January 13, 2022
    Applicant: Advanced Accelerator Applications International SA
    Inventors: Francesca Orlandi, Lorenza Fugazza, Donato Barbato, Mattia Tedesco, Lorenzo Sacchetti
  • Publication number: 20210379213
    Abstract: The present invention relates to radionuclide complex solutions of high concentration and of high chemical stability, that allows their use as drug product for diagnostic and/or therapeutic purposes. The stability of the drug product is achieved by at least one stabilizer against radiolytic degradation. The use of two stabilizers introduced during the manufacturing process at different stages was found to be of particular advantage.
    Type: Application
    Filed: March 22, 2021
    Publication date: December 9, 2021
    Inventors: Francesco de Palo, Lorenza Fugazza, Donato Barbato, Maurizio Mariani, Daniela Chicco, Giovanni Tesoriere, Clementina Brambati
  • Publication number: 20210379212
    Abstract: The present invention relates to radionuclide complex solutions of high concentration and of high chemical stability, that allows their use as drug product for diagnostic and/or therapeutic purposes. The stability of the drug product is achieved by at least one stabilizer against radiolytic degradation. The use of two stabilizers introduced during the manufacturing process at different stages was found to be of particular advantage.
    Type: Application
    Filed: March 22, 2021
    Publication date: December 9, 2021
    Inventors: Francesco de Palo, Lorenza Fugazza, Donato Barbato, Maurizio Mariani, Daniela Chicco, Giovanni Tesoriere, Clementina Brambati
  • Publication number: 20210316019
    Abstract: The present disclosure relates to the synthesis of radionuclide complex solutions, in particular for their use in the commercial production of radioactive drug substances, for diagnostic and/or therapeutic purposes. In particular, the synthesis method comprises the following steps in the following order: a. providing a radionuclide precursor solution into a first vial, b. transferring the radionuclide precursor solution into a reactor, c. providing a reaction buffer solution into said first vial containing residual radionuclide precursor solution, d. transferring the buffer reaction solution and residual radionuclide precursor solution from said first vial into the reactor, e. transferring a peptide solution comprising the somatostatin receptor binding peptide linked to a chelating agent, into the reactor, f. reacting the somatostatin receptor binding peptide linked to a chelating agent with said radionuclide in the reactor to obtain the radionuclide complex, g. recovering said radionuclide complex.
    Type: Application
    Filed: October 31, 2019
    Publication date: October 14, 2021
    Applicant: Advanced Accelerator Applications (Italy) SRL
    Inventors: Lorenza Fugazza, Francesco de Palo, Donato Barbato, Maurizio F. Mariani, Giovanni Tesoriere, Clementina Brambati
  • Publication number: 20200353106
    Abstract: The present invention relates to radionuclide complex solutions of high concentration and of high chemical stability, that allows their use as drug product for diagnostic and/or therapeutic purposes. The stability of the drug product is achieved by at least one stabilizer against radiolytic degradation. The use of two stabilizers introduced during the manufacturing process at different stages was found to be of particular advantage.
    Type: Application
    Filed: March 23, 2020
    Publication date: November 12, 2020
    Inventors: Francesco de Palo, Lorenza Fugazza, Donato Barbato, Maurizio Mariani, Daniela Chicco, Giovanni Tesoriere, Clementina Brambati
  • Publication number: 20200131224
    Abstract: The present disclosure relates to the synthesis of radionuclide complex solutions, in particular for their use in the commercial production of radioactive drug substances, for diagnostic and/or therapeutic purposes. In particular, the synthesis method comprises the following steps in the following order: a. providing a radionuclide precursor solution into a first vial, b. transferring the radionuclide precursor solution into a reactor, c. providing a reaction buffer solution into said first vial containing residual radionuclide precursor solution, d. transferring the buffer reaction solution and residual radionuclide precursor solution from said first vial into the reactor, e. transferring a peptide solution comprising the somatostatin receptor binding peptide linked to a chelating agent, into the reactor, f. reacting the somatostatin receptor binding peptide linked to a chelating agent with said radionuclide in the reactor to obtain the radionuclide complex, g. recovering said radionuclide complex.
    Type: Application
    Filed: April 24, 2019
    Publication date: April 30, 2020
    Applicant: Advanced Accelerator Applications (Italy) S.R.L.
    Inventors: Lorenza Fugazza, Francesco De Palo, Donato Barbato, Maurizio F. Mariani, Giovanni Tesoriere, Clementina Brambati
  • Patent number: 10596278
    Abstract: The present invention relates to radionuclide complex solutions of high concentration and of high chemical stability, that allows their use as drug product for diagnostic and/or therapeutic purposes. The stability of the drug product is achieved by at least one stabilizer against radiolytic degradation. The use of two stabilizers introduced during the manufacturing process at different stages was found to be of particular advantage.
    Type: Grant
    Filed: October 30, 2018
    Date of Patent: March 24, 2020
    Assignee: ADVANCED ACCELERATOR APPLICATIONS (ITALY) S.R.L.
    Inventors: Francesco de Palo, Lorenza Fugazza, Donato Barbato, Maurizio Mariani, Daniela Chicco, Giovanni Tesoriere, Clementina Brambati
  • Patent number: 10596276
    Abstract: The present invention relates to radionuclide complex solutions of high concentration and of high chemical stability, that allows their use as drug product for diagnostic and/or therapeutic purposes. The stability of the drug product is achieved by at least one stabilizer against radiolytic degradation. The use of two stabilizers introduced during the manufacturing process at different stages was found to be of particular advantage.
    Type: Grant
    Filed: October 30, 2018
    Date of Patent: March 24, 2020
    Assignee: ADVANCED ACCELERATOR APPLICATIONS (ITALY) S.R.L.
    Inventors: Francesco de Palo, Lorenza Fugazza, Donato Barbato, Maurizio Mariani, Daniela Chicco, Giovanni Tesoriere, Clementina Brambati
  • Publication number: 20200038526
    Abstract: It is described a composition comprising lyophilized rhAnnexin V-128 suitable for the preparation of 99mTc-rhAnnexin V-128 formulations suitable for intravenous administration.
    Type: Application
    Filed: October 11, 2017
    Publication date: February 6, 2020
    Applicant: Advanced Accelerator Applications International S.A.
    Inventors: Lorenza Fugazza, Maurizio Franco Mariani, Francesca Orlandi, Daniela Chicco, Donato Barbato
  • Publication number: 20200030464
    Abstract: The present invention relates to radionuclide complex solutions of high concentration and of high chemical stability, that allows their use as drug product for diagnostic and/or therapeutic purposes. The stability of the drug product is achieved by at least one stabilizer against radiolytic degradation. The use of two stabilizers introduced during the manufacturing process at different stages was found to be of particular advantage.
    Type: Application
    Filed: October 30, 2018
    Publication date: January 30, 2020
    Inventors: Francesco de Palo, Lorenza Fugazza, Donato Barbato, Maurizio Mariani, Daniela Chicco, Giovanni Tesoriere, Clementina Brambati
  • Publication number: 20200030467
    Abstract: The present invention relates to radionuclide complex solutions of high concentration and of high chemical stability, that allows their use as drug product for diagnostic and/or therapeutic purposes. The stability of the drug product is achieved by at least one stabilizer against radiolytic degradation. The use of two stabilizers introduced during the manufacturing process at different stages was found to be of particular advantage.
    Type: Application
    Filed: October 30, 2018
    Publication date: January 30, 2020
    Inventors: Francesco de Palo, Lorenza Fugazza, Donato Barbato, Maurizio Mariani, Daniela Chicco, Giovanni Tesoriere, Clementia Brambati